Cargando…
2041. Impact of T2 Candida Panel on Species Specific Anti-fungal De-escalation
BACKGROUND: Empiric antifungal treatment is recommended in patients with suspected candidemia given the 20–40% associated mortality. T2Candida Panel (T2) is approved for the rapid detection directly on a blood sample of candidemia caused by C. albicans/C. tropicalis (CA/CT), C. parapsilosis (CP), C....
Autores principales: | Chaudhry, Zohra, Vahia, Amit, Askar, Sally, Hussain, Noman, Hameed, Mujtaba, Alangaden, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252867/ http://dx.doi.org/10.1093/ofid/ofy210.1697 |
Ejemplares similares
-
247. Evaluation of the T2Candida Panel as an Antifungal Stewardship Tool in Transplant and Non-Transplant Patients at a Tertiary Care Center
por: Sarfraz. Chaudhry, Zohra, et al.
Publicado: (2019) -
1134. Novel T2Candida Panel Assay Compared With Blood Cultures for Detection of Candidemia in Transplant and Non-Transplant Patients
por: Hussain, Noman, et al.
Publicado: (2018) -
444. Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers in Southeast Michigan
por: Vahia, Amit T, et al.
Publicado: (2020) -
210. Improved Antimicrobial Utilization in the Emergency Department: Impact of a Point of Care Polymerase Chain Reaction Test for The Rapid Detection Influenza
por: Williams, Jonathan, et al.
Publicado: (2018) -
522. The Simple and Novel SAS Score to Predict Mortality at Presentation in 2541 Hospitalized COVID-19 Patients
por: Acosta, Tommy J Parraga, et al.
Publicado: (2020)